Autophagic Activation and Decrease of Plasma Membrane Cholesterol Contribute to Anticancer Activities in Non-Small Cell Lung Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Autophagic Activation and Decrease of Plasma Membrane Cholesterol Contribute to Anticancer Activities in Non-Small Cell Lung Cancer
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 19, Pages 5967
Publisher
MDPI AG
Online
2021-10-09
DOI
10.3390/molecules26195967
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma
- (2019) Fahim Ahmad et al. Cancers
- Aggregation of lipid rafts activates c-met and c-Src in non-small cell lung cancer cells
- (2018) Juan Zeng et al. BMC CANCER
- Dietary Cholesterol Intake and Risk of Lung Cancer: A Meta-Analysis
- (2018) Xiaojing Lin et al. Nutrients
- Inhibition of Akt/mTOR/p70S6K Signaling Activity With Huangkui Capsule Alleviates the Early Glomerular Pathological Changes in Diabetic Nephropathy
- (2018) Wei Wu et al. Frontiers in Pharmacology
- Effects of para-toluenesulfonamide intratumoral injection on pulmonary adenoid cystic carcinoma complicating with severe central airway obstruction: a 5-year follow-up study
- (2018) Wei-Jie Guan et al. Journal of Thoracic Disease
- Overcoming resistance in non-small-cell lung cancer: A practical lesson for the medicinal chemist
- (2018) Giovanni Ribaudo et al. ARCHIV DER PHARMAZIE
- Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
- (2018) Ugo Testa et al. Cancers
- The Antitumor Activity of a Lead Thioxanthone is Associated with Alterations in Cholesterol Localization
- (2018) Raquel Lima et al. MOLECULES
- Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
- (2018) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Para-Toluenesulfonamide Induces Anti-tumor Activity Through Akt-Dependent and -Independent mTOR/p70S6K Pathway: Roles of Lipid Raft and Cholesterol Contents
- (2018) Jui-Ling Hsu et al. Frontiers in Pharmacology
- mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells
- (2017) Walaa Eid et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Role of Cholesterol in Cancer
- (2016) Omer F. Kuzu et al. CANCER RESEARCH
- 4E-BP1, a multifactor regulated multifunctional protein
- (2016) Xiaoyu Qin et al. CELL CYCLE
- Effects of para–toluenesulfonamide intratumoral injection on non-small cell lung carcinoma with severe central airway obstruction: A multi-center, non-randomized, single-arm, open-label trial
- (2016) Shi-yue Li et al. LUNG CANCER
- Para-toluenesulfonamide induces tongue squamous cell carcinoma cell death through disturbing lysosomal stability
- (2015) Zhe Liu et al. ANTI-CANCER DRUGS
- Translational control by oncogenic signaling pathways
- (2015) Beichen Gao et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Squalene Synthase Induces Tumor Necrosis Factor Receptor 1 Enrichment in Lipid Rafts to Promote Lung Cancer Metastasis
- (2014) Yi-Fang Yang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mitochondrial cholesterol: mechanisms of import and effects on mitochondrial function
- (2014) Laura A. Martin et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Self-consumption: the interplay of autophagy and apoptosis
- (2014) Guillermo Mariño et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Interaction of membrane/lipid rafts with the cytoskeleton: Impact on signaling and function
- (2013) Brian P. Head et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- The Prognostic Value of Phosphorylated AKT Expression in Non-Small Cell Lung Cancer: A Meta-Analysis
- (2013) Zhi-Xin Qiu et al. PLoS One
- Translational Homeostasis via eIF4E and 4E-BP1
- (2012) Alan G. Hinnebusch MOLECULAR CELL
- Mitochondrial Fusion Is Essential for Steroid Biosynthesis
- (2012) Alejandra Duarte et al. PLoS One
- Puncture injection of para-toluenesulfonamide combined with chemoembolization for advanced hepatocellular carcinoma
- (2012) Qing He WORLD JOURNAL OF GASTROENTEROLOGY
- Dietary cholesterol intake and cancer
- (2011) J. Hu et al. ANNALS OF ONCOLOGY
- Activation of mammalian target of rapamycin pathway confers adverse outcome in nonsmall cell lung carcinoma
- (2011) Dan Liu et al. CANCER
- Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein Kinase (MAPK) and Phosphatidylinositol-3-kinase (PI3K)/AKT pathways
- (2011) Jun-ichi Hanai et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Overexpression of the mammalian target of rapamycin (mTOR) and angioinvasion are poor prognostic factors in early stage NSCLC: A verification study
- (2011) K. Gately et al. LUNG CANCER
- PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains
- (2011) X. Gao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- New Hierarchical Phosphorylation Pathway of the Translational Repressor eIF4E-binding Protein 1 (4E-BP1) in Ischemia-Reperfusion Stress
- (2010) María I. Ayuso et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Akt Signaling by Exclusion from Lipid Rafts in Normal and Transformed Epidermal Keratinocytes
- (2010) Damien Calay et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Gemcitabine plus cisplatin chemotherapy with concurrent para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall cell lung cancer larger than 3 cm in the greatest dimension
- (2009) Jianxing He et al. ANTI-CANCER DRUGS
- Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-β-cyclodextrin, not 2,6-di-O-methyl-α-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells
- (2009) Keiichi Motoyama et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
- (2009) Sandra Ghayad et al. Recent Patents on Anti-Cancer Drug Discovery
- Mitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular Carcinoma
- (2008) J. Montero et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More